AUS
NZ
UK
CA
USA
IND
Healthcare
How Medtronic (NYSE:MDT) Reacts To Market Sentiment In S&P 500 Futures
February 20, 2026 12:00 AM PST| By Anmol KhazanchiMedtronic (NYSE:MDT) excels in medical technology, with a diverse portfolio and innovation driving growth. Its performance impacts the S&P 500 futures and shapes healthcare's future.
AbbVie (NYSE:ABBV) At Midday As Traders Watch Nyse Composite Closely
February 19, 2026 04:06 PM PST| By Anmol KhazanchiAbbVie operates in the health care sector, within the biopharmaceutical space where research, regulatory progress, manufacturing reliability, and commercial execution can all influence daily trading.
Artivion Inc (NYSE:AORT) Devices Strategy And Nyse Composite Index Sector Rotation
February 19, 2026 01:32 PM PST| By Anmol KhazanchiArtivion operates in the cardiovascular medical device sector, supplying technologies used in surgical and clinical settings that focus on the heart and major blood vessels. This area of healthcare is shaped by product quality.
Johnson and Johnson Surges in s&p 500 Spotlight
February 19, 2026 01:32 PM PST| By Anmol KhazanchiJohnson and Johnson gains attention in the s&p 500 after hitting a fresh peak, announcing manufacturing expansion, regulatory progress, and updated quarterly earnings.
Johnson Johnson (NYSE:JNJ) Dates Near Dow Jones Industrials Average Key Moves Today
February 19, 2026 01:11 PM PST| By Anmol KhazanchiJohnson & Johnson operates within the healthcare sector, spanning medicines and a range of health-related products and services. Within this sector, established issuers often maintain regular.
GSK (NYSE:GSK) Sees Options Surge in NYSE Composite
February 19, 2026 12:49 PM PST| By Anmol KhazanchiGSK draws attention on the NYSE Composite following heightened derivatives activity, shareholder disclosures, and ongoing developments in global pharmaceutical operations.
Neurocrine (NASDAQ:NBIX) Downgrade Shifts Focus Across Nasdaq Index
February 19, 2026 12:00 AM PST| By Anmol KhazanchiNeurocrine (NASDAQ:NBIX) enters renewed Nasdaq Index focus after a brokerage downgrade, as investors reassess valuation, margin durability, and institutional positioning.
Xenon (NASDAQ:XENE) Short-Term Positioning Shifts In Nasdaq Futures
February 19, 2026 12:00 AM PST| By Anmol KhazanchiXenon (NASDAQ:XENE) enters Nasdaq Futures focus as heavy put option activity and steady institutional rotation shape short-term sentiment in biotech trading.
Rhythm (NASDAQ:RYTM) Capital Discipline Gains Nasdaq 100 Index Focus
February 19, 2026 12:00 AM PST| By Anmol KhazanchiRhythm (NASDAQ:RYTM) re-enters Nasdaq 100 Index discussions after a coverage update, as institutional activity and pipeline focus shape biotech positioning.
How Alnylam (NASDAQ:ALNY) Is Reframing Nasdaq Index Fund Allocation Trends
February 19, 2026 12:00 AM PST| By Anmol KhazanchiAlnylam Pharmaceuticals (NASDAQ:ALNY) draws Nasdaq index fund focus following a rating upgrade and solid quarterly performance despite mixed consensus results.
TC Energy (NYSE:TRP) Brokerage Rating Shift Explains Why Ratings Changes Move Markets
February 18, 2026 04:29 PM PST| By Anmol KhazanchiTC Energy Corp (NYSE:TRP) with pipeline corridors and related facilities that support the steady flow of natural gas and other energy products between production regions, storage hubs, and demand centres.
Glaukos (NYSE:GKOS) Jumps After Qtrly Revenue Beat
February 18, 2026 02:18 PM PST| By Anmol KhazanchiGlaukos Corporation performance within NYSE Composite reflects recent earnings results, evolving ophthalmic technologies, and ongoing commercial expansion across glaucoma and corneal care segments.
Bristol Myers Squibb (NYSE:BMY) Delivers Stability While S&P 500 Stays Volatile
February 18, 2026 01:17 PM PST| By Anmol KhazanchiThe healthcare sector includes global biopharma groups that develop, manufacture, and distribute prescription therapies across areas such as oncology, immunology, and cardiovascular care.
Is Prenetics Global (NASDAQ:PRE) Surprising Markets In Nasdaq Today Session
February 18, 2026 12:00 AM PST| By Anmol KhazanchiPrenetics Global (NASDAQ:PRE) drew attention in Nasdaq Today trading after surpassing projections, signaling restructuring progress and continued volatility in the diagnostics sector.
Fortrea (NASDAQ:FTRE) Trading Momentum Aligns With Nasdaq Futures Trends
February 18, 2026 12:00 AM PST| By Anmol KhazanchiFortrea (NASDAQ:FTRE) remains active in Nasdaq futures discussions as coverage consensus, balanced liquidity, and steady institutional engagement shape its CDMO sector positioning.
Eli Lilly (NASDAQ:LLY) Market Reaction Mirrors S&P 500 Futures Movement
February 18, 2026 12:00 AM PST| By Anmol KhazanchiEli Lilly (NYSE:LLY) advances on strong margins and institutional accumulation, with performance increasingly aligned to movements in S&P 500 futures positioning.
Medtronic (NYSE:MDT) Balance Sheet Discipline Underscored In S&P 500 Index
February 18, 2026 12:00 AM PST| By Anmol KhazanchiMedtronic (NYSE:MDT) remains a steady large-cap healthcare name in the S&P 500 index, supported by diversified devices, solid margins, and sustained institutional participation.
Abbott (NYSE:ABT) Diagnostics Strength Supports Russell 1000 ETF Narrative
February 18, 2026 12:00 AM PST| By Anmol KhazanchiAbbott (NYSE:ABT) maintains valuation stability in the Russell 1000 ETF, backed by diversified healthcare segments, recurring demand, and institutional support.
Cogent Biosciences (NASDAQ:COGT) Progress Versus Market Expectations This Quarter
February 17, 2026 04:57 PM PST| By Anmol KhazanchiCogent Biosciences operates in the Canadian-relevant life sciences landscape as a clinical-stage biopharmaceutical participant within the healthcare sector. The company’s work centres on discovering and developing.
Disc Medicine (NASDAQ:IRON) Drives Biotechnology Shifts In Views On Development Strategy
February 17, 2026 04:51 PM PST| By Anmol KhazanchiDisc Medicine operates within the clinical stage biotechnology sector, where research driven drug development is shaped by trial design, scientific validation, and regulatory checkpoints.
